Demographics and Clinical Characteristics of COVID-19-vaccinated Patients Admitted to ICU: A Multicenter Cohort Study from India (PostCoVac Study-COVID Group)

BACKGROUND: Emergency authorization and approval were given for the coronavirus disease-19 (COVID-19) vaccines. The efficacy reported after phase III trials were 70.4% and 78% for Covishield and Covaxin, respectively. In this study, we aim to analyze the risk factors, which were associated with mort...

Descripción completa

Detalles Bibliográficos
Autores principales: Havaldar, Amarja Ashok, Prakash, Jay, Kumar, Sanjeev, Sheshala, Kaladhar, Chennabasappa, Abhilash, Thomas, Ria Rachel, Sushmitha, EA Chinny, Khan, Mohd Saif, Kumar, Raman, Kindo, Srishti, Singh, Ritu, Kartik, Munta, Swamy, Akshay Hiruyur Manjunatha, Raj, John Michael, Thomas, Tinku, Selvam, Sumithra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983652/
https://www.ncbi.nlm.nih.gov/pubmed/36873595
http://dx.doi.org/10.5005/jp-journals-10071-24349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983652/
https://www.ncbi.nlm.nih.gov/pubmed/36873595
http://dx.doi.org/10.5005/jp-journals-10071-24349

Ejemplares similares